Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+6.86M
-
Total reported value, excl. options
-
$1.89B
-
Value change
-
+$96.4M
-
Put/Call ratio
-
0.66
-
Number of buys
-
126
-
Number of sells
-
-92
-
Price
-
$16.00
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q2 2025
248 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q2 2025.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 240M outstanding shares and own 49.1% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (13.9M shares), AXON ENTERPRISE, INC. (9M shares), T. Rowe Price Investment Management, Inc. (6.52M shares), FMR LLC (6.16M shares), Voss Capital, LP (5.15M shares), MORGAN STANLEY (4.65M shares), Clal Insurance Enterprises Holdings Ltd (3.91M shares), Invesco Ltd. (3.51M shares), Pertento Partners LLP (2.95M shares), and BlackRock, Inc. (2.94M shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.